(Q40260805)

19 September 2017

Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents (English)

1 reference

Anticonvulsant hypersensitivity syndrome

19 September 2017

1 reference

Cornelia S Seitz

1

1 reference

19 September 2017

Petra Pfeuffer

2

1 reference

19 September 2017

Petra Raith

3

1 reference

19 September 2017

Eva B Bröcker

4

1 reference

19 September 2017

Axel Trautmann

5

1 reference

19 September 2017

language of work or name

1 reference

1 November 2006

1 reference

Annals of Allergy, Asthma & Immunology

19 September 2017

1 reference

19 September 2017

97

1 reference

19 September 2017

5

1 reference

19 September 2017

698-702

1 reference

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Antiepileptic drug hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Anticonvulsant hypersensitivity syndrome to carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Antiepileptic hypersensitivity syndrome: clinicians beware and be aware

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

The anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Mechanisms of drug reactions: the metabolic track

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Hypersensitivity syndrome caused by amitriptyline administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

A method for estimating the probability of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Cross-sensitivity and the anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Cross Hypersensitivity Syndrome between Phenytoin and Carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Possible atypical cross-sensitivity between phenytoin and carbamazepine in the anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Lamotrigine-associated anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events. Retrospective review of old data and call for new investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Familial occurrence of hypersensitivity to phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Concordance of primary generalised epilepsy and carbamazepine hypersensitivity in monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

A case of photosensitivity and contact allergy to systemic tricyclic drugs, with unusual features

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Carbamazepine interference with an immune assay for tricyclic antidepressants in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

The usefulness of skin tests to prove drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Patch testing in cutaneous reactions caused by carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

Anticonvulsant hypersensitivity syndrome: lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961103-9

7 January 2021

10.1016/S1081-1206(10)61103-9

Identifiers

DOI

1 reference

19 September 2017

1 reference